bovin
viral
diarrhea
virus
bvdv
signific
impact
beef
dairi
product
worldwid
infect
widespread
cattl
popul
mani
product
system
vaccin
util
bvdv
strain
hallmark
advers
affect
immun
system
mani
compon
innat
acquir
system
bvdv
caus
primari
infect
diseas
role
pathogenesi
agent
underscor
complex
viralebacteri
synergi
greater
understand
role
persist
infect
pi
anim
result
suscept
femal
infect
critic
stage
pregnanc
permit
acknowledg
major
sourc
infect
suscept
anim
understand
role
pi
transmit
infect
complic
infect
focu
attempt
better
diagnos
remov
pi
anim
vaccin
address
need
immun
popul
especi
breed
femal
herd
biosecur
detect
remov
pi
effect
vaccin
tool
potenti
success
bvdv
control
bovin
viral
diarrhea
viru
bvdv
infect
occur
cattl
variou
form
bvdv
infect
manifest
singl
organ
involv
involv
sever
organ
system
andor
work
concert
infecti
agent
caus
clinic
ill
bvdv
tropism
mani
organ
includ
respiratori
tract
digest
tract
lymphoid
system
reproduct
tract
fetu
thu
overli
simplist
classifi
infect
specif
diseas
bvdv
except
persist
infect
pi
calv
born
suscept
femal
expos
pregnanc
mucos
diseas
md
pi
calv
superinfect
second
relat
cytopath
strain
bvdv
role
bvdv
synergist
mix
infect
agent
like
due
well
known
immunosuppress
review
pogeit
studi
bvdv
innat
immun
numer
refer
effect
lymphoid
organ
reduct
bcell
tcell
neutrophil
impair
bacteria
kill
decreas
chemotaxi
decreas
lymphocyt
prolifer
decreas
immunoglobulin
secret
circul
likewis
may
reduct
thelper
tcytotox
lymphocyt
addit
immunosuppress
bovin
acquir
immun
system
humor
cell
mediat
innat
immun
system
bovin
respiratori
tract
impair
bvdv
thu
bvdv
often
associ
secondari
coinfect
agent
bvdv
divers
group
virus
antigen
genom
properti
two
major
genotyp
subclassif
subgenotyp
base
genom
antigen
differ
twelv
al
b
us
three
major
subtyp
singl
report
us
bvdv
also
categor
base
presenc
absenc
viral
induc
cytopatholog
infect
cell
cultur
cytopath
cp
noncytopath
ncp
biotyp
ncp
strain
predomin
natur
infect
recoveri
diagnost
laboratori
access
indic
approxim
ncp
compar
approxim
cp
strain
ncp
strain
predomin
natur
infect
cattl
interestingli
almost
us
licens
vaccin
contain
cp
strain
distribut
bvdv
subtyp
us
cattl
larg
base
genom
test
subgenotyp
isol
diagnost
laboratori
access
repres
ill
cattl
cattl
present
necropsi
test
detect
pi
cattl
subsequ
genotyp
pi
strain
antibodi
test
alway
give
true
indic
infect
bvdv
vaccin
wide
use
vaccin
induc
antibodi
indistinguish
natur
infect
serolog
test
place
antibodi
survey
even
absenc
vaccin
may
indic
widespread
pi
cattl
respect
popul
expos
suscept
cattl
respond
activ
infect
detect
seroposit
statu
test
pi
cattl
variou
popul
geographi
andor
manag
beef
breed
herd
stocker
feedlot
dairi
milk
herd
calf
raiser
report
calv
beef
herd
five
state
test
bvdv
pi
statu
herd
least
one
pi
calf
calv
test
pi
studi
pi
calv
dam
also
pi
anoth
studi
test
pi
cattl
select
herd
cattl
pi
bvdv
herd
pi
cattl
statewid
studi
calv
iowa
beef
breed
herd
pi
rate
bvdv
herd
pi
anim
calv
beef
breed
herd
south
central
oklahoma
north
texa
test
bvdv
pi
statu
calv
pi
herd
one
pi
calv
studi
pi
calv
pi
dam
initi
studi
us
report
bvdv
subtyp
pi
calv
beef
breed
herd
isol
studi
feedlot
cattl
indic
cattl
enter
feedlot
bvdv
pi
subsequ
studi
cattl
southeastern
state
us
enter
feedlot
evalu
variou
test
pi
cattl
detect
pi
studi
initi
studi
us
report
distribut
bvdv
subtyp
pi
cattl
enter
feedlot
iowa
studi
cattl
enter
cattl
feedlot
cattl
pi
limit
studi
preval
bvdv
dairi
industri
studi
young
bull
dairi
calv
arizona
report
calv
pi
companion
studi
beef
calv
pi
thu
appear
variou
studi
cattl
differ
manag
calv
breed
herd
feedlot
beef
oper
dairi
calv
rang
posit
pi
calv
distribut
bvdv
subgenotyp
us
report
support
publish
studi
studi
report
indic
distribut
bvdv
case
northwestern
us
beef
dairi
sampl
subtyp
list
isol
posit
bvdv
oklahoma
diagnost
laboratori
access
repres
clinic
ill
cattl
necropsi
case
primarili
oklahoma
state
repres
includ
kansa
texa
arkansa
posit
identifi
affin
subtyp
particular
organ
system
identifi
sourc
respiratori
digest
mixedmultipl
organ
abort
pi
bvdv
subtyp
isol
pi
anim
diagnost
laboratori
access
dairi
oper
state
princip
eastern
state
us
origin
bulk
milk
sampl
infect
cattl
thu
two
differ
diagnost
laboratori
similar
distribut
three
bvdv
subtyp
later
studi
australian
us
isol
report
distribut
bvdv
subtyp
pi
cattl
southwest
us
feedlot
similarli
report
refer
among
isol
thu
appear
us
predomin
bvdv
subtyp
us
base
analysi
diagnost
laboratori
access
studi
pi
cattl
predomin
consider
interest
usda
licens
mlv
kill
vaccin
avail
market
us
contain
case
bvdv
infect
occur
cattl
variou
manifest
diseas
form
tabl
creat
uniqu
diseas
form
nearli
imposs
viru
may
infect
multipl
organ
system
coupl
abil
bvdv
caus
immunosuppress
transient
infect
anim
often
result
mix
infect
agent
make
classif
difficult
hallmark
bvdv
infect
immunosuppress
host
respons
infect
result
increas
incid
virul
secondari
infect
virus
bacteria
mycoplasma
bvdv
may
infect
singl
organ
system
often
infect
multipl
organ
result
system
diseas
mani
virus
bvdv
infect
postnat
suscept
calf
often
inappar
one
import
featur
pregnant
femal
bvdv
infect
pregnanc
discuss
fact
infect
pregnant
femal
may
lead
detriment
effect
fetu
without
dam
exhibit
clinic
sign
numer
survey
nonvaccin
cattl
unvaccin
herd
indic
antibodi
posit
cattl
younger
calf
usual
target
acut
infect
loss
matern
antibodi
follow
ingest
colostrum
mean
halflif
passiv
acquir
bvdv
antibodi
approxim
day
actual
age
calf
becom
suscept
depend
amount
bvdv
antibodi
absorb
colostrum
dose
viru
incub
suscept
viru
expos
calf
day
viremia
typic
less
day
may
longer
depend
viru
strain
stress
pathogen
bvdv
may
caus
respiratori
infect
acut
primari
uncompl
agent
diseas
clinic
sign
postexposur
shown
experiment
infect
gener
viralebacteri
synergi
occur
virus
predispos
bovin
secondari
infect
compromis
host
defens
mechan
multipl
mechan
upper
respiratori
tract
nasal
turbin
mucos
epitheli
cell
damag
alter
mucociliari
clearanc
bacteri
attach
growth
colon
tracheal
mucos
epitheli
cell
damag
mucociliari
apparatu
compromis
bacteria
attach
growth
colon
innat
defens
system
lung
compromis
viral
infect
macrophag
neutrophil
major
tabl
diseas
form
bovin
viral
diarrhea
virus
e
immunosuppress
associ
mani
form
respiratori
e
acut
uncompl
coinfect
agent
digest
tract
e
acut
diseas
coinfect
thrombocytopeniahemorrhag
form
mucos
diseas
reproduct
tractfet
infect
persist
infect
pi
cattl
phagocyt
cell
innat
host
defens
system
either
deplet
destroy
impair
antibacteri
properti
acquir
immun
system
tcell
cell
mediat
bcell
humor
system
suppress
bvdv
strain
potenti
alter
one
multipl
mechan
result
impair
host
respons
infect
bvdv
shown
experiment
challeng
bvdv
exposur
bacteri
challeng
work
concert
agent
includ
bovin
bovin
respiratori
syncyti
viru
brsv
bovin
rotaviru
mannheimia
haemolytica
addit
studi
feedlot
cattl
natur
occur
brd
indic
infect
occur
bvdv
along
pathogen
includ
viru
brsv
bovin
adenoviru
bav
haemolytica
pasteurella
multocida
mycoplasma
spp
final
support
evid
bvdv
associ
brd
report
fatal
feedlot
pneumonia
recoveri
bvdv
agent
includ
bovin
coronaviru
bcv
haemolytica
p
multocida
histophilu
somni
variou
mycoplasma
spp
studi
feedlot
pneumonia
oklahoma
feedlot
three
us
bvdv
subtyp
recov
lung
interestingli
vaccin
viru
cp
nadl
recov
lung
calv
die
soon
process
feedlot
virus
recov
shortli
mlv
vaccin
differenti
vaccin
field
strain
origin
relationship
determin
among
infecti
agent
lesion
feedlot
perform
studi
signific
statist
p
valu
sever
comparison
calv
infect
bvdv
field
strain
becam
ill
sooner
die
earlier
feedlot
bvdv
neg
subtyp
differ
well
ncp
cattl
treat
earlier
shorter
treatment
interv
day
initi
treatment
death
fatal
diseas
onset
die
earlier
feedlot
day
death
feedlot
ncp
cattl
treat
earlier
well
cattl
ncp
isol
lung
relat
recoveri
haemolytica
similar
find
observ
recoveri
cp
vaccin
strain
haemolytica
cp
vaccin
strain
posit
calv
acut
pneumonia
recoveri
cp
strain
acut
case
treat
earli
feedlot
may
tempor
event
associ
mlv
vaccin
rather
virul
factor
lesion
develop
vaccin
virus
sometim
recov
within
day
vaccin
digest
tract
diseas
caus
bvdv
occur
age
neonat
adult
primari
form
transient
infect
usual
occur
cattl
six
month
age
acut
form
manifest
fever
anorexia
depress
possibl
ulcerseros
oral
mucosa
tongu
potenti
diarrhea
due
immunosuppress
effect
viru
unusu
find
concurr
infect
ecoli
salmonella
spp
cryptosporidiosi
rotaviru
bcv
viru
damag
epitheli
structur
digest
tract
includ
ulcer
eros
potenti
alway
entir
digest
tract
affin
lymphoid
tissu
peyer
patch
intestin
may
affect
acut
bvdv
diseas
extens
mucos
lesion
larynx
esophagu
glossiti
bronchopneumonia
high
morbid
mortal
observ
commerci
feedlot
affect
cattl
neg
pi
statu
determin
ear
notch
neg
elisa
affect
cattl
posit
cattl
like
expos
pi
cattl
transit
pi
shipment
gross
microscop
lesion
acut
bvdv
case
distinguish
observ
lesion
mucos
diseas
acut
digest
tract
diseas
like
caus
ncp
strain
bvdv
contrast
mucos
diseas
describ
calv
may
undergo
acut
infect
hemorrhag
syndrom
diseas
character
thrombocytopenia
bloodi
diarrhea
hemorrhag
visibl
mucou
membran
bleed
inject
site
death
ncp
bvdv
strain
biotyp
involv
diseas
form
mechan
hemorrhag
thrombocytopenia
fulli
understood
diseas
often
fatal
mucos
diseas
md
thought
mani
classic
form
bvdv
low
morbid
high
mortal
md
result
persist
infect
calf
discuss
fetal
infect
infect
ncp
strain
develop
diseas
infect
relat
cp
viru
infect
relat
cp
strain
like
result
origin
ncp
mutatingevolv
cp
strain
diseas
character
sever
digest
tract
diseas
ulcerseros
potenti
throughout
entir
digest
tract
skin
lesion
hoof
lesion
includ
interdigit
space
diseas
uniformli
fatal
diseas
could
similar
sever
form
acut
digest
tract
diseas
differenti
acut
diseas
two
featur
md
cp
ncp
isol
affect
anim
necropsi
tissu
anim
md
evid
pi
statu
ie
posit
skin
test
sampl
detect
immunohistochemistri
ihc
antigen
captur
elisa
ace
concern
mlv
bvdv
vaccin
may
contribut
md
mlv
bvdv
vaccin
almost
case
contain
cp
biotyp
theori
cp
vaccin
strain
would
relat
ncp
strain
pi
anim
howev
low
rate
pi
cattl
enter
feedlot
less
cattl
receiv
mlv
bvdv
vaccin
entri
process
extrem
low
incid
md
feedlot
support
connect
mlv
bvdv
vaccin
also
one
studi
demonstr
vaccin
pi
calv
differ
mlv
vaccin
induc
md
associ
mlv
vaccin
realiti
calv
respond
activ
antibodi
respons
bvdv
immunogen
vaccin
outcom
infect
suscept
heifercow
expos
bvdv
depend
upon
gestat
age
pregnanc
exposur
day
prior
earli
pregnanc
suggest
bvdv
suscept
femal
may
neg
effect
concept
andor
implant
fertil
ovum
result
lower
concept
rate
repeat
cycl
observ
clinic
abort
may
occur
result
fetal
exposur
stage
day
ncp
cp
infect
label
indic
us
bvdv
mlv
vaccin
list
approv
use
pregnant
cowsheif
select
mlv
vaccin
us
label
indic
use
pregnant
femal
approv
process
indic
stipul
specif
vaccin
given
prior
breed
within
specifi
time
usual
within
year
congenit
defect
malform
may
occur
result
bvdv
infect
day
depend
critic
age
organ
develop
wide
rang
defect
may
occur
includ
cerebellar
hypoplasia
microencephali
hydrocephalu
hydranencephali
porencephali
hypomyelin
cataract
micropthalmia
retin
degener
optic
neuriti
thymic
hypoplasia
hypotrichosi
derang
osteogenesi
brachygnath
growth
retard
refer
citat
clinician
awar
varieti
potenti
congenit
defect
bvdv
circul
among
pregnant
femal
pregnant
femal
gestat
age
pregnanc
fetus
infect
ncp
strain
day
may
surviv
carri
term
born
aliv
surviv
lifetim
shedder
viru
calv
refer
persist
infect
pi
suscept
femal
expos
interv
give
birth
pi
calf
howev
may
abort
develop
congenit
defect
cp
biotyp
fetal
infect
result
pi
calv
appear
caus
persist
infect
fetu
andor
establish
immunotoler
infect
biotyp
pi
calf
import
reservoir
viru
shed
viru
secretionsexcret
lifetim
anim
pi
calv
immunotoler
infect
ncp
strain
may
respond
antibodi
product
either
heterolog
field
strain
vaccin
strain
fetal
infect
last
trimest
may
occur
organogenesi
complet
develop
immun
system
infect
last
trimest
may
result
calv
born
bvdv
antibodi
precolostr
serum
without
detect
viru
fetal
immun
system
clear
viru
term
congenit
infect
use
calv
viru
neg
bvdv
antibodi
posit
birth
appear
greater
risk
ill
postnat
life
calv
born
antibodi
neg
extentpreval
congenit
infect
calv
remain
determin
recent
report
diseas
outbreak
dairi
herd
underscor
point
varieti
diseas
outcom
may
result
bvdv
fetal
infect
isol
holstein
dairi
calv
dairi
herd
experienc
prematur
birth
brachygnath
growth
retard
malform
brain
cranium
rare
extracrani
skelet
malform
cattl
may
respond
bvdv
infect
humor
antibodi
cell
mediat
tcell
respons
exposur
experiment
viral
challeng
exposur
natur
occur
field
strain
vaccin
calv
expos
intranas
administ
viru
repres
sever
nonvaccin
bvdv
strain
individu
calv
respond
serum
antibodi
product
calv
seroneg
bvdv
expos
intranas
either
ncp
cp
strain
respond
activ
respons
increas
tcell
post
infect
interestingli
calv
bvdv
antibodi
deriv
matern
respond
activ
tcell
respons
exposur
virul
bvdv
system
activ
immun
respons
indic
reveal
humor
cell
mediat
immun
exposur
bvdv
serum
circul
leukocyt
evalu
studi
design
evalu
activ
immun
respons
lung
expos
cattl
calv
receiv
bvdv
intrabronchi
sequenti
bronchoalveolar
lavag
sampl
postexposur
evalu
humor
cell
mediat
respons
expos
calv
respond
increas
antibvdv
iga
antibvdv
igg
lavag
fluid
total
number
lavag
fluid
also
increas
increas
bvdv
antibodi
lung
increas
tcell
coincid
clearanc
challeng
bvdv
secondari
viral
challeng
result
increas
bvdv
antibodi
increas
tcell
lung
cattl
respond
mlv
kill
bvdv
vaccin
antibodi
tcell
respons
suscept
calv
receiv
mlv
vaccin
contain
respond
increas
serum
bvdv
antibodi
increas
bvdv
activ
tcell
respons
also
observ
calv
matern
antibodi
bvdv
respond
activ
tcell
mlv
bvdv
vaccin
histor
thought
kill
inactiv
viral
vaccin
would
stimul
tcell
respons
often
give
mlv
advantag
kill
vaccin
recent
studi
report
wherebi
calv
given
bvdv
kill
vaccin
contain
immunogen
immun
respons
investig
calv
respond
increas
serum
antibodi
also
antigen
specif
tcell
subset
studi
natur
occur
infect
feedlot
cattl
indic
bvdv
infect
often
result
mix
sourc
cattl
commingl
cattl
receiv
bvdv
vaccin
acut
sampl
collect
entri
day
follow
convalesc
sampl
week
later
shown
seroconvert
bvdv
case
evid
pi
anim
group
suggest
exposur
either
immedi
prior
commingl
shipment
infect
due
acut
infect
abil
pi
cattl
expos
larg
number
suscept
cattl
shown
multipl
studi
feedlot
condit
pi
bvdv
cattl
often
effici
infect
suscept
contact
suscept
contact
becam
infect
exposur
pen
pi
cattl
immun
bvdv
measur
abil
resist
challeng
mechan
recoveri
protect
host
defens
mechan
bvdv
infect
like
includ
bvdv
specif
antibodi
activ
tcell
subset
along
innat
immun
tradit
passiv
immun
consid
protect
cattl
challeng
virul
virus
howev
studi
indic
protect
immun
respons
mount
calv
passiv
immun
bvdv
protect
reflect
serum
bvdv
antibodi
calv
colostr
antibodi
infect
virul
viru
protect
yet
calv
increas
serum
antibodi
level
eventu
declin
calv
still
protect
infect
virul
viru
undetect
antibodi
time
exposur
abil
calv
mount
activ
tcell
subset
respons
mlv
vaccin
possess
matern
antibodi
suggest
activ
bvdv
tcell
help
confer
protect
bvdv
colostrum
deriv
immun
factor
host
protect
viral
challeng
potenti
inhibit
respons
vaccin
efficaci
colostr
immun
depend
level
antibodi
present
anim
challeng
vaccin
difficult
ascrib
specif
titer
protect
suscept
differ
test
use
laboratori
challeng
viru
may
vari
along
anim
phenotyp
manag
genet
variat
colostr
antibodi
absorb
calf
halflif
serum
approxim
day
studi
evalu
effect
matern
immun
vaccin
kill
vaccin
contain
calv
passiv
serum
titer
higher
fail
develop
activ
antibodi
respons
either
immunogen
two
dose
titer
half
calv
develop
increas
antibodi
titer
either
immunogen
protect
afford
presenc
passiv
deriv
serum
antibodi
calv
challeng
highli
virul
bvdv
strain
calv
neutral
antibodi
titer
lower
fever
system
spread
viru
postchalleng
calv
titer
sever
clinic
diseas
calv
neutral
titer
expos
pi
calv
becam
virem
studi
use
pi
calv
challeng
model
indic
pregnant
vaccin
heifer
immunogen
serum
titer
protect
fetal
infect
eight
control
heifer
two
vaccin
heifer
titer
infect
fetus
two
control
heifer
control
heifer
abort
collect
date
antibodi
titer
gave
equivoc
result
fetus
heifer
titer
protect
yet
four
fetus
becam
infect
fetu
heifer
titer
becam
infect
fetus
heifer
titer
becam
infect
fetus
heifer
titer
becam
infect
fetus
heifer
titer
becam
infect
one
heifer
titer
normal
fetu
becom
infect
virem
exposur
pi
calv
studi
evalu
anim
health
statu
cattl
feedlot
entri
predict
feedlot
perform
carcass
evalu
antibodi
level
sever
brd
pathogen
measur
either
individu
anim
herd
basi
calv
predictor
perform
measur
immun
pathogen
calv
low
level
antibodi
increas
treatment
cost
decreas
net
valu
return
owner
calv
treat
twice
lower
level
treat
pi
anim
believ
import
sourc
infect
postnat
anim
pi
anim
lifetim
shedder
high
level
viru
nasal
secret
excret
sourc
viru
excret
via
nasal
secret
pi
cattl
illustr
examin
respiratori
tract
nasal
mucosa
lung
pi
calv
use
ihc
bvdv
antigen
detect
respiratori
tract
squamou
columnar
epithelium
mix
tubuloalveolar
gland
nasal
mucosa
secretori
cell
ductular
epithelium
nasal
mucu
secret
cell
tracheobronchi
gland
well
alveolar
macrophag
thu
secret
nasal
caviti
pi
anim
doubt
contain
consider
viru
high
titer
bvdv
found
nasal
swab
materi
taken
pi
calv
eleven
month
long
studi
pi
cattl
cattl
level
infect
nasal
swab
titrat
rang
log
per
ml
nasal
fluid
question
aris
might
role
cattl
acut
infect
bvdv
transmit
viru
challeng
studi
focu
detect
viru
system
infect
blood
peripher
leukocyt
littl
inform
avail
quantiti
viru
nasal
swab
acut
infect
anim
report
sole
qualit
posit
neg
order
look
dynam
infect
nonvaccin
anim
may
expos
vaccin
anim
look
shed
vaccin
viru
control
detect
seroconvers
perhap
viremia
field
studi
use
cattl
feedlot
viral
isol
serolog
gave
use
inform
acut
infect
two
studi
calv
purchas
auction
sent
nearbi
order
buyer
barn
ship
feedlot
calv
commingl
mix
sourc
receiv
bvdv
vaccin
held
feedlot
day
respect
blood
nasal
swab
collect
weekli
viru
isol
studi
ranch
calv
mix
order
buyer
calv
feedlot
includ
one
pi
calf
illustr
short
rang
infect
acut
infect
anim
day
bvdv
isol
acut
infect
anim
found
day
blood
day
nasal
swab
thu
short
rang
infect
pi
calf
posit
blood
nasal
swab
throughout
studi
later
studi
order
buyer
auction
market
calv
bvdv
pi
calv
shipment
rang
isol
acut
infect
calv
day
blood
day
calf
posit
nasal
swab
anoth
studi
use
pi
bvdv
challeng
calv
previous
vaccin
nonvaccin
control
indic
acut
infect
viru
isol
posit
blood
posit
day
nasal
swab
day
studi
use
pi
bvdv
calv
challeng
vaccin
nonvaccin
rang
infect
acut
infect
calv
blood
posit
day
day
nasal
sampl
thu
rang
natur
occur
infect
acut
infect
calv
short
base
studi
day
blood
rare
one
day
day
nasal
swab
potenti
acut
infect
anim
may
shed
extern
secret
amount
viru
shed
like
threshold
infect
suscept
contact
presenc
pi
cattl
feedlot
shown
advers
effect
product
feedlot
studi
report
cattl
enter
feedlot
pi
use
penmat
pi
cattl
adjac
pen
risk
initi
treatment
brd
cattl
expos
pi
cattl
chronic
ill
cattl
pi
fatal
case
feedlot
pi
initi
case
brd
attribut
pi
exposur
note
prior
pi
cattl
extrem
effici
transmit
viru
suscept
contact
two
studi
pi
cattl
abl
infect
suscept
contact
pen
continu
pi
cattl
studi
design
evalu
variou
level
exposur
pi
anim
starter
feedlot
day
effect
feedlot
perform
protocol
minim
exposur
pi
cattl
feedlot
use
procedur
identifi
pi
calf
either
leav
pi
calf
pen
remov
pi
pen
follow
pen
along
pen
adjac
pen
pi
pen
pi
remov
studi
involv
cattl
pi
anim
pen
least
pi
anim
pi
cattl
remov
pen
would
direct
exposur
pi
pen
pi
adjac
pen
perform
outcom
improv
slightli
risk
exposur
decreas
compar
effect
pi
exposur
direct
exposur
pi
calf
remain
pen
pen
adjac
pen
pi
remain
pen
without
exposur
pi
cattl
total
cost
per
anim
basi
popul
exposur
pi
bvdv
cattl
fatal
perform
loss
studi
gave
insight
potenti
decreas
advers
effect
pi
calf
exposur
starter
feedlot
reduc
exposur
identif
remov
pi
calf
lotpen
studi
repres
larg
popul
cattl
sever
bvdv
genotyp
present
pi
cattl
pi
distribut
larg
gener
popul
larg
number
pen
involv
illustr
variabl
individu
pen
perform
cost
gain
cog
suggest
potenti
virul
bvdv
strain
pen
expos
adjac
pen
variabl
greater
lot
direct
exposur
pi
anim
twenti
fifti
lot
direct
exposur
group
valu
equal
less
mean
unexpos
group
howev
lot
unexpos
group
higher
cog
mean
direct
expos
group
point
underscor
issu
studi
larg
number
pen
pi
cattl
account
variabl
would
includ
virul
viru
well
animaltoanim
variat
fate
pi
cattl
illustr
studi
feedlot
condit
pi
cattl
die
studi
examin
necropsi
anim
fatal
rate
compar
nonpi
cattl
pi
anim
attribut
md
brd
bloat
identifi
addit
studi
pi
cattl
consid
chronic
ill
sold
salvag
slaughter
compar
nonpi
cattl
mean
length
ill
fatal
md
case
day
die
brd
day
mani
pi
cattl
feedlot
may
die
earli
yet
known
may
complet
finish
period
market
likewis
veterinarian
produc
beef
dairi
cowherd
milk
oper
report
pi
cattl
may
live
year
pi
cattl
immunotoler
ncp
strain
infect
utero
howev
pi
calv
may
still
respond
heterolog
bvdv
strain
natur
infect
vaccin
increas
neutral
antibodi
yet
may
respond
immunogen
haemolytica
vaccin
survivabilitydeath
loss
pi
cattl
illustr
feedlot
studi
infect
associ
death
unexpect
say
immunocompromis
year
long
feedlot
studi
fatal
pneumonia
calv
die
brd
necropsi
sampl
examin
histopatholog
lesion
infecti
agent
recov
feedlot
perform
evalu
studi
brd
fatal
case
pi
pi
cattl
associ
p
valu
recoveri
archanobacterium
pyogen
recoveri
bvdv
field
strain
lesion
lobar
bronchopneumonia
case
chronic
pneumonia
commingl
pi
anim
product
set
use
recent
investig
determin
presenc
pi
anim
impact
product
determin
vaccin
efficaci
studi
demonstr
pi
calv
may
predispos
cattl
infect
demonstr
abil
serv
challeng
suscept
cattl
studi
evalu
vaccin
efficaci
infect
suscept
calv
fetal
infect
diseas
studi
conduct
demonstr
viralebacteri
synergi
could
enhanc
use
pi
bvdv
cattl
prior
bacteri
challeng
suscept
calv
expos
pi
calv
h
challeng
intratrach
haemolytica
pi
challeng
result
reduc
antibodi
respons
haemolytica
leukotoxin
postchalleng
increas
rectal
temperatur
system
bvdv
pi
calf
exposur
prior
haemolytica
challeng
offer
use
model
pathogenesi
viralebacteria
synergi
brd
two
studi
use
either
pi
calv
challeng
vaccin
nonvaccin
control
provid
evid
vaccin
protect
system
infect
viremia
subsequ
pi
calf
exposur
addit
studi
done
use
pi
calv
challeng
vaccin
nonvaccin
measur
protect
fetal
infectiondiseas
studi
pi
calf
challeng
result
infect
control
measur
viremia
infect
fetus
calv
born
control
nonvaccin
thu
use
pi
calv
vaccin
efficaci
studi
mirror
natur
occur
infect
cattl
oper
treatment
pi
anim
littl
potenti
achiev
complet
viru
free
statu
pi
anim
definit
immunotoler
viru
present
bodi
system
tissu
secretesexcret
larg
quantiti
viru
current
antivir
compound
effect
decreas
viral
titer
exampl
attempt
treat
pi
calv
illustr
lack
success
pi
calv
treat
recombin
human
interferon
everi
day
week
antivir
activ
pi
calv
result
interferon
treatment
calv
develop
advers
immunolog
hematolog
effect
indic
toxic
effect
treatment
select
potenti
antivir
challeng
feder
regul
involv
approv
like
approv
treatment
due
safeti
issu
includ
food
safeti
prevent
bvdv
requir
three
compon
identif
sourc
infect
cattl
particularli
pi
anim
remov
anim
biosecur
effect
implement
continu
mainten
barrier
entri
viru
immun
popul
base
proper
vaccin
critic
issu
relat
control
bvdv
along
knowledg
gap
relev
bvdv
outlin
recent
review
articl
identif
pi
anim
remov
begin
control
program
numer
diagnost
test
avail
detect
pi
anim
includ
use
viral
isol
cell
cultur
use
peripher
blood
identif
bvdv
antigen
formalin
fix
skin
tissu
immunohistochemistri
hc
identif
bvdv
antigen
supernat
skin
tissu
sampl
antigen
captur
elisa
ace
pcr
test
gel
base
real
time
use
supernat
skin
tissu
sampl
limit
number
diagnost
laboratori
provid
pcr
test
bulk
milk
sampl
individu
dairi
identifi
herd
infect
mani
viral
isol
cell
cultur
two
consecut
test
week
apart
gold
standard
pi
statu
two
posit
test
week
apart
rule
acut
infect
other
use
ihc
formalin
fix
tissu
standard
well
pi
statu
pool
sampl
pcr
test
use
laboratori
reduc
cost
test
wherea
lab
chosen
offer
pool
test
due
valid
technic
issu
pool
test
neg
entir
number
repres
anim
consid
neg
posit
pool
found
individu
sampl
must
test
mani
veterinarian
produc
prefer
use
test
design
one
anim
time
ace
skin
sampl
ihc
fix
tissu
anim
found
pi
recommend
remov
popul
ideal
isol
prevent
exposur
cattl
especi
suscept
femal
pi
cattl
permit
process
meat
consumpt
unless
treat
antibiot
drug
requir
hold
period
process
highli
recommend
pi
cattl
reenter
market
system
return
herd
final
option
euthanasia
biosecur
bvdv
entryreentri
similar
diseas
john
diseas
ideal
cattl
outsid
bull
heiferscow
steer
test
neg
bvdv
condit
purchas
howev
cattl
test
prior
entri
premis
isol
resid
anim
particularli
pregnant
anim
test
result
known
cattl
return
livestock
show
bull
heifer
raiser
isol
well
approxim
week
special
comment
appli
enter
pregnant
heiferscow
may
test
neg
could
carri
infect
fetu
thu
pregnant
femal
enter
herd
held
isol
calf
born
test
bvdv
also
cattl
breed
oper
use
purchas
semen
artifici
insemin
obtain
semen
facil
known
bvdv
free
procedur
anim
test
use
embryo
transfer
advanc
bovin
genet
requir
vigil
use
bvdv
free
donor
recipi
well
bvdv
free
serum
obtain
recipi
femal
requir
test
anim
purchas
breed
oper
maintain
breed
herd
purchas
stocker
calv
forag
purchas
anim
kept
separ
breed
herd
mix
taken
place
test
bvdv
emphasi
biosecur
focus
cattl
pi
anim
prevent
exposur
bvdv
recent
year
evid
show
deer
may
infect
bvdv
via
exposur
pi
cattl
also
suscept
pregnant
deer
expos
pi
deer
gave
birth
live
fawn
one
fawn
found
pi
thu
interfac
wildlif
domest
cattl
rais
issu
interspeci
transmiss
bvdv
natur
rang
condit
beef
dairi
herd
role
pi
deer
acut
infect
deer
transmiss
bvdv
suscept
cattl
deserv
investig
current
product
system
beef
dairi
determin
rel
role
infect
deer
might
impact
control
program
vaccin
critic
point
bvdv
control
immun
cattl
popul
import
control
program
also
lessen
impact
diseas
improv
product
beef
dairi
produc
enhanc
econom
return
produc
vaccin
effect
protect
acut
infectionsdiseas
equal
import
protect
fetal
infect
result
pi
calv
control
bvdv
effect
cycl
pi
calv
need
broken
pi
anim
consid
major
reservoir
infect
kill
mlv
vaccin
avail
us
bvdv
mlv
vaccin
capabl
induc
wide
rang
antibodi
sever
strain
also
bvdv
mlv
may
advantag
kill
vaccin
one
dose
give
rapid
protect
earli
day
vaccin
antibodi
respons
mlv
kill
bvdv
vaccin
declin
time
anim
low
antibodi
level
anamnest
respons
follow
revaccin
current
vaccin
protocol
call
annual
revaccin
current
licensur
vaccin
must
pass
efficaci
challeng
studi
use
acut
challeng
suscept
cattl
howev
recent
us
select
vaccin
receiv
usda
approv
label
claim
protect
fetal
infect
andor
diseas
mlv
vaccin
gain
use
recent
time
kill
vaccin
vaccin
calv
two
dose
usual
recommend
follow
anoth
dose
prior
breed
vaccin
pregnant
cow
mlv
use
base
approv
licensur
respect
vaccin
bvdv
mlv
vaccin
suscept
cow
could
result
fetal
infect
diseas
fetu
vaccin
bvdv
critic
control
must
use
appropri
affect
control
biosecur
elimin
pi
anim
good
partner
vaccin
bvdv
control
program
